eplerenone and Hypertension--Renovascular

eplerenone has been researched along with Hypertension--Renovascular* in 2 studies

Other Studies

2 other study(ies) available for eplerenone and Hypertension--Renovascular

Article	Year
Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:3 Topics: Amlodipine; Antihypertensive Agents; Dihydropyridines; Eplerenone; Humans; Hypertension, Renovascular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nephrotic Syndrome; Proteinuria; Radiography; Spironolactone; Treatment Outcome	2011
Successful blood pressure control with additive administration of eplerenone, an aldosterone receptor blocker, in a patient with bilateral renovascular hypertension treated with angioplasty. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:22 A 29-year-old woman with refractory hypertension who previously suffered from subarchnoid hemorrhage visited our facility. The diagnosis of renovascular hypertension due to fibromuscular dysplasia was made based on a high level of plasma renin activity (PRA) and aldosterone concentration (AC), and computed tomographic image of bilateral renal artery stenosis/obstruction. Angioplasty, which could be performed only to the left renal artery, failed to regain sufficient BP control. The addition of eplerenone, an aldosterone receptor blocker, to the conventional antihypertensive drugs successfully and safely lowered BP and preserved the renal function despite the persistence of high PRA and AC values. Topics: Adult; Angioplasty; Eplerenone; Female; Humans; Hypertension, Renovascular; Mineralocorticoid Receptor Antagonists; Remission Induction; Spironolactone	2010

Article

Year

Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension.

Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:3

Topics: Amlodipine; Antihypertensive Agents; Dihydropyridines; Eplerenone; Humans; Hypertension, Renovascular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nephrotic Syndrome; Proteinuria; Radiography; Spironolactone; Treatment Outcome

2011

Successful blood pressure control with additive administration of eplerenone, an aldosterone receptor blocker, in a patient with bilateral renovascular hypertension treated with angioplasty.

Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:22

A 29-year-old woman with refractory hypertension who previously suffered from subarchnoid hemorrhage visited our facility. The diagnosis of renovascular hypertension due to fibromuscular dysplasia was made based on a high level of plasma renin activity (PRA) and aldosterone concentration (AC), and computed tomographic image of bilateral renal artery stenosis/obstruction. Angioplasty, which could be performed only to the left renal artery, failed to regain sufficient BP control. The addition of eplerenone, an aldosterone receptor blocker, to the conventional antihypertensive drugs successfully and safely lowered BP and preserved the renal function despite the persistence of high PRA and AC values.

Topics: Adult; Angioplasty; Eplerenone; Female; Humans; Hypertension, Renovascular; Mineralocorticoid Receptor Antagonists; Remission Induction; Spironolactone

2010